株式会社Epigeneron

Epigeneron Inc. is a Drug discovery and detection of gene mutation Company.

Operating in insurtech based in Tokyo, Japan, 株式会社Epigeneron operates.

Profile

"Epigeneron Inc. is a pioneering Insurtech company focused on drug discovery and gene mutation detection. Leveraging cutting-edge genomic technologies, Epigeneron is dedicated to developing therapeutic solutions for challenging diseases such as cancer and neurological disorders. Their proprietary gene locus-specific ChIP method enables the identification of drug targets, leading to the creation of innovative treatments for patients in need. Additionally, Epigeneron's ORNi-PCR® technology accelerates gene mutation detection and enhances the precision of next-generation sequencing (NGS) analysis. This advancement not only improves the accuracy of genetic diagnostics but also boosts productivity in research institutions. Epigeneron's commitment to advancing precision medicine and genetic research underscores their significant contribution to the healthcare industry."

株式会社Epigeneron is positioned in insurtech, a segment that rewards a clear, focused offering.

The company is recorded as being based in Tokyo, Japan.

It is recorded at the Plug and Play portfolio startup stage.

Website: epigeneron.com